Michael Fries

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes et al. · The Lancet Respiratory Medicine · 2016 · 191 citations · Full text

Open-label Extension Trial, Long-term Efficacy, Immunology +2

International Study on Microcirculatory Shock Occurrence in Acutely Ill Patients*

Namkje AR Vellinga, E. Christiaan Boerma, Matty Koopmans et al. · Critical Care Medicine · 2014 · 147 citations

Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury

Philip D Loetscher, Jan Rossaint, Rolf Rossaint et al. · Critical Care · 2009 · 138 citations · Full text

Microcirculation during cardiac arrest and resuscitation

Michael Fries, Max Harry Weil, Yun-Te Chang et al. · Critical Care Medicine · 2006 · 113 citations

Comparison of early cognitive function and recovery after desflurane or sevoflurane anaesthesia in the elderly: a double-blinded randomized controlled trial

Daniel Rörtgen, J Kloos, Michael Fries et al. · British Journal of Anaesthesia · 2009 · 102 citations · Full text

Neuropsychological Functioning, Anesthesia, Sevoflurane Anaesthesia +13